The use of afala in complex treatment of patients with chronic prostatitis improves the efficiency of therapy and prolongs its positive results. The preparation is well tolerated, has no contraindication, and can be combined with other drugs. Afala is indicated for patients with stages II and IIIa chronic prostatitis from the first day of therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10517-009-0693-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!